| Multiwall carbon nanotube scaffolds for tissue engineering purposes A Abarrategi, MC Gutiérrez, C Moreno-Vicente, MJ Hortigüela, V Ramos, ... Biomaterials 29 (1), 94-102, 2008 | 534 | 2008 |
| Titanium coatings and surface modifications: toward clinically useful bioactive implants A Civantos, E Martínez-Campos, V Ramos, C Elvira, A Gallardo, ... ACS Biomaterials Science & Engineering 3 (7), 1245-1261, 2017 | 315 | 2017 |
| Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia D Passaro, A Di Tullio, A Abarrategi, K Rouault-Pierre, K Foster, ... Cancer cell 32 (3), 324-341. e6, 2017 | 236 | 2017 |
| Osteosarcoma: cells‐of‐origin, cancer stem cells, and targeted therapies A Abarrategi, J Tornin, L Martinez-Cruzado, A Hamilton, ... Stem cells international 2016 (1), 3631764, 2016 | 220 | 2016 |
| Tissue-specific decellularization methods: rationale and strategies to achieve regenerative compounds U Mendibil, R Ruiz-Hernandez, S Retegi-Carrion, N Garcia-Urquia, ... International journal of molecular sciences 21 (15), 5447, 2020 | 214 | 2020 |
| Bone microenvironment signals in osteosarcoma development A Alfranca, L Martinez-Cruzado, J Tornin, A Abarrategi, T Amaral, ... Cellular and Molecular Life Sciences 72, 3097-3113, 2015 | 203 | 2015 |
| Chitosan scaffolds for osteochondral tissue regeneration A Abarrategi, Y Lópiz‐Morales, V Ramos, A Civantos, L López‐Durán, ... Journal of Biomedical Materials Research Part A 95 (4), 1132-1141, 2010 | 119 | 2010 |
| Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches A Abarrategi, SA Mian, D Passaro, K Rouault-Pierre, W Grey, D Bonnet Journal of Experimental Medicine 215 (3), 729-743, 2018 | 115 | 2018 |
| Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells R Rubio, A Abarrategi, J Garcia‐Castro, L Martinez‐Cruzado, C Suarez, ... Stem cells 32 (5), 1136-1148, 2014 | 108 | 2014 |
| Biological Properties of Solid Free Form Designed Ceramic Scaffolds with BMP-2: In Vitro and In Vivo Evaluation A Abarrategi, C Moreno-Vicente, FJ Martínez-Vázquez, A Civantos, ... PloS one 7 (3), e34117, 2012 | 104 | 2012 |
| Versatile humanized niche model enables study of normal and malignant human hematopoiesis A Abarrategi, K Foster, A Hamilton, SA Mian, D Passaro, J Gribben, ... The Journal of clinical investigation 127 (2), 543-548, 2017 | 98 | 2017 |
| Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populations BD Lopez‐Ayllon, V Moncho‐Amor, A Abarrategi, II de Cáceres, ... Cancer medicine 3 (5), 1099-1111, 2014 | 87 | 2014 |
| Chitosan film as rhBMP2 carrier: delivery properties for bone tissue application A Abarrategi, A Civantos, V Ramos, JV Sanz Casado, JL López-Lacomba Biomacromolecules 9 (2), 711-718, 2008 | 80 | 2008 |
| In vivo comparison of the effects of rhBMP-2 and rhBMP-4 in osteochondral tissue regeneration Y Lópiz-Morales, A Abarrategi, V Ramos, C Moreno-Vicente, ... Eur Cell Mater 20 (367), e78, 2010 | 73 | 2010 |
| Improvement of porous β-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application A Abarrategi, C Moreno-Vicente, V Ramos, I Aranaz, JV Sanz Casado, ... Tissue Engineering Part A 14 (8), 1305-1319, 2008 | 70 | 2008 |
| Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model P Barba-Recreo, T Georgiev-Hristov, ER Bravo-Burguillos, A Abarrategi, ... Journal of Cranio-Maxillofacial Surgery 43 (7), 1161-1168, 2015 | 62 | 2015 |
| Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia A Waclawiczek, A Hamilton, K Rouault-Pierre, A Abarrategi, MG Albornoz, ... The Journal of clinical investigation 130 (6), 3038-3050, 2020 | 57 | 2020 |
| Use of rhBMP-2 activated chitosan films to improve osseointegration JL Lopez-Lacomba, JM Garcia-Cantalejo, JV Sanz Casado, A Abarrategi, ... Biomacromolecules 7 (3), 792-798, 2006 | 56 | 2006 |
| The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia A Di Tullio, K Rouault-Pierre, A Abarrategi, S Mian, W Grey, J Gribben, ... Nature communications 8 (1), 1679, 2017 | 52 | 2017 |
| Clonal dynamics in osteosarcoma defined by RGB marking S Gambera, A Abarrategi, F González-Camacho, Á Morales-Molina, ... Nature communications 9 (1), 3994, 2018 | 45 | 2018 |
